There is still very little data and no evidence supporting an association between PALB2 mutations and prostate cancer risk [13, 36–39] although several pedigrees have been presented and a possible trend toward aggressive disease in carriers has been noted [39]. The gene discussed is PALB2; the disease is prostate cancer.